巨大盆腔复发性胃肠间质瘤术中大出血的处理
被引量:1
摘要
腹膜后肿瘤由于解剖部位特殊和肿瘤的血供特点.术中大出血较为常见。我院于2007年9月在手术切除一巨大盆腔复发性胃肠间质瘤(gastrointestinal stromal tumor.GIST)时,出现了术中大出血,现将处理体会总结如下。
出处
《中华胃肠外科杂志》
CAS
2008年第6期596-596,共1页
Chinese Journal of Gastrointestinal Surgery
参考文献3
-
1李荣,郑伟.腹膜后肿瘤术中联合血管切除及血管重建[J].中国实用外科杂志,2007,27(7):528-530. 被引量:8
-
2张立阳,张思源,桑新亭,于健春,何小东,郑朝纪,邱辉忠.90例原发性腹膜后肿瘤治疗分析[J].外科理论与实践,2006,11(4):344-345. 被引量:1
-
3沈琳.胃肠道间质瘤的内科治疗[J].中国实用外科杂志,2006,26(8):588-591. 被引量:14
二级参考文献33
-
1沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27
-
2I-ShyanSheen,Kuo-ShyangJeng,Shou-ChuanShih,Chih-RoaKao,Wen-HsingChang,Horng-YuanWang,Po-ChuanWang,Tsang-EnWang,Li-RungShyung,Chih-ZenChen.Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(2):187-192. 被引量:41
-
3宋少柏,王平,梁法启,蒋彦永.累及重要血管的腹膜后肿瘤手术处理经验(附20例报告)[J].中华外科杂志,1995,33(6):342-344. 被引量:21
-
4Heslin MJ,Lewis JJ,Nadler E,et al.Prognostic factors associated with long-term survival for retroperitoneal sarcoma:implications for management[J].Clin Oncol,1997,15(8):2832.
-
5Bautista N,Su W,O'Connell TX.Retroperitoneal softtissue sarcomas:prognosis and treatment of primary and recurrent disease[J].Am Surg,2000,66(9):832-836.
-
6Joensuu H,Fletcher C,Dimitrijevic S,et al.Management of malignant gastrointestinal stromal tumours[J].Lancet Oncol,2002,3(11):655-664.
-
7DeMatteo RP.The GIST of targeted cancer therapy:A tumor (gastrointestinal stromal tumor),a mutated gene (c-kit),and a molecular inhibitor (STI571)[J].Ann Surg Oncol,2002,9(9):831-839.
-
8Eilber FC,Rosen G,Forscher C,et al.Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas[J].Ann Surg Oncol,1999,6(7):645-650.
-
9Karakousis CP,Kontzoglou K,Driscoll DL.Intraperitoneal chemotherapy in disseminated abdominal sarcoma[J].Ann Surg Oncol,1997,4(6):496-498.
-
10Rajan DK,Soulen MC,Clark TW,et al.Sarcomas metastatic to the liver:response and survival after cisplatin,doxorubicin,mitomycin-C,Ethiodol,and polyvinyl alcohol chemoembolization[J].J Vasc Interv Radiol,2001,12(2):187-193.
共引文献20
-
1于威,于宏,刘宝华,张楠,刘铜军.十二指肠间质瘤误诊为十二指肠溃疡1例诊治体会[J].中国实验诊断学,2007,11(2):268-269.
-
2刘建国,梁保华,李奇,姜鸿偦,梁俊峰.胃肠道间质瘤3例报告[J].中原医刊,2007,34(22):72-73.
-
3丁家增,彭承宏,匡洁,金筱泰,严佶祺,李勤裕,杨卫平,李宏为.累及下腔静脉的腹膜后肿瘤的外科处理(附14例报告)[J].外科理论与实践,2008,13(3):210-212. 被引量:5
-
4朱彦军,宋爱华,车淑珍.胃肠间质瘤并消化道出血病人的观察与护理[J].家庭护士(专业版),2008,6(21):1927-1928.
-
5黄斌,赵纪春,马玉奎.原发性腹膜后肿瘤的诊断和治疗[J].中国普外基础与临床杂志,2008,15(8):607-608. 被引量:12
-
6黄勇,何院林,丁晓华.腹膜内胃肠外间质细胞瘤2例的诊治分析[J].中国民康医学,2008,20(19):2338-2338. 被引量:1
-
7袁宁,李强,吴淑金.胃肠道间质瘤的临床研究进展[J].医学综述,2008,14(24):3719-3722. 被引量:2
-
8王强,寇有为.甲磺酸伊马替尼治疗胃肠间质瘤术后复发35例报告[J].中国实用外科杂志,2009,29(6):510-510. 被引量:3
-
9卫勃,陈凛,李沛雨,吴欣,唐云,郝璐,梁发启,李荣.腹膜后肿瘤切除术中单纯结扎和切除下腔静脉的可行性[J].南方医科大学学报,2009,29(5):922-924. 被引量:9
-
10孙喜元.胃肠道间质瘤的临床诊治分析(附36例报告)[J].实用临床医药杂志,2009,13(3):68-68. 被引量:6
同被引文献21
-
1沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27
-
2蔡国响,蔡三军,师英强,杜春燕,侯英勇,徐烨,廉朋,管祖庆,施达仁.26例胃肠道间质瘤肝转移的临床特征和生存分析[J].中华消化杂志,2005,25(9):521-525. 被引量:27
-
3Posther KE,Wells SA Jr.The future of surgical research:the role of the American College of Surgeons Oncology Group.Eur J Surg Oncol,2005,31 (6):695 -701.
-
4Dematteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival.Ann Surg,2000,231 (1):51-58.
-
5Nunobe S,Sano T,Shimada K,et al.Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointetinal leiomyosarcomas.Jpn J Clin Oncol,2005,35 (6):338-341.
-
6Blanke CD,Demetri GD,yon Mehren M,et al.Long-term results from a randomized phase Ⅱ trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.J Clin Oncol,2008,26(4):620-625.
-
7Rutkowski P,Nowecki Z,Nyckowski P,et al.Surgicaltreatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.J Surg Oncol,2006,93(4):304-311.
-
8Blanke CD,Rankin C,Demetri GD,et al.PhaseⅢ randomized,intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromaltumors expressing the kit receptor tyrosine kinase:S0033.J Clin Oncol,2008,26(4):626-632.
-
9Casali PG,Verweij J,Kotasek D,et al.Imatinib mesylate in advanced gastrointestinal stromal tumors (GIST):Survival analysis of the intergroup EORTC/ISG/AGITG randomized trial in 946patients.Eur J Cancer,2005,3 Suppl:201-203.
-
10Gronchi A,Fiore M,Miselli F,et al.Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.Ann Surg,2007,245 (3):341-346.
-
1章斐然,谢澳斯,陈君填,李威.复发性胃肠间质瘤的临床治疗[J].医学理论与实践,2014,27(16):2114-2116. 被引量:1
-
2吴荣寿,邬林泉,邵江华,张惊玲.复发性胃肠间质瘤多发肝脏转移一例外科治疗[J].肝胆胰外科杂志,2016,28(1):75-77.
-
3柴素伟.试论复发性胃肠间质瘤患者的临床治疗体会[J].大家健康(学术版),2016(3). 被引量:1
-
4沈琳,金懋林.甲磺酸伊马替尼治疗复发或转移性胃肠间质瘤[J].中华肿瘤杂志,2004,26(11):697-699. 被引量:27
-
5Lipcan III M.T.,Loren D.E.,Palazzo J.P.,樊菁.Carney综合征的复发性胃肠间质瘤的超声内镜诊断[J].世界核心医学期刊文摘(胃肠病学分册),2005,0(5):17-17.